EPS for Aceto (ACET) Expected At $0.23; 1 Analysts Bullish Virtus Investment Partners, Inc. (VRTS)

January 18, 2018 - By Migdalia James

Analysts expect Aceto Corporation (NASDAQ:ACET) to report $0.23 EPS on February, 1.They anticipate $0.01 EPS change or 4.17% from last quarter’s $0.24 EPS. ACET’s profit would be $6.93M giving it 12.15 P/E if the $0.23 EPS is correct. After having $0.30 EPS previously, Aceto Corporation’s analysts see -23.33% EPS growth. The stock decreased 1.67% or $0.19 during the last trading session, reaching $11.18. About 274,315 shares traded. Aceto Corporation (NASDAQ:ACET) has declined 30.78% since January 18, 2017 and is downtrending. It has underperformed by 47.48% the S&P500.

Among 9 analysts covering Virtus Investment Partners (NASDAQ:VRTS), 1 have Buy rating, 0 Sell and 8 Hold. Therefore 11% are positive. Virtus Investment Partners had 30 analyst reports since August 4, 2015 according to SRatingsIntel. Credit Suisse downgraded Virtus Investment Partners, Inc. (NASDAQ:VRTS) on Monday, October 31 to “Neutral” rating. Jefferies downgraded the stock to “Hold” rating in Thursday, March 10 report. On Monday, October 23 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The firm earned “Equal-Weight” rating on Monday, October 30 by Barclays Capital. The rating was maintained by Sandler O’Neill with “Hold” on Wednesday, January 10. The company was upgraded on Monday, November 2 by Sandler O’Neill. The firm has “Hold” rating given on Tuesday, September 22 by Zacks. The rating was maintained by Jefferies with “Hold” on Tuesday, October 10. As per Friday, July 15, the company rating was upgraded by Credit Suisse. As per Wednesday, June 14, the company rating was maintained by Jefferies. See Virtus Investment Partners, Inc. (NASDAQ:VRTS) latest ratings:

10/01/2018 Broker: Sandler O’Neill Rating: Hold New Target: $132.0 Maintain
10/01/2018 Broker: Jefferies Rating: Hold New Target: $136.0 Maintain
09/01/2018 Broker: Goldman Sachs Rating: Hold New Target: $130.0 Upgrade
02/01/2018 Broker: Sandler O’Neill Rating: Hold New Target: $126.0 Maintain
14/11/2017 Broker: Jefferies Rating: Hold New Target: $120.0 Maintain
30/10/2017 Broker: Barclays Capital Rating: Equal-Weight Old Target: $116 New Target: $125 Maintain
23/10/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $122 New Target: $121 Maintain
10/10/2017 Broker: Jefferies Rating: Hold New Target: $127.0 Maintain
10/10/2017 Broker: Barclays Capital Rating: Equal-Weight Old Target: $113 New Target: $116 Maintain
09/10/2017 Broker: Bank of America Old Rating: Underperform New Rating: Neutral Old Target: $112 New Target: $130 Upgrade

The stock increased 0.70% or $0.9 during the last trading session, reaching $130.35. About 44,338 shares traded. Virtus Investment Partners, Inc. (NASDAQ:VRTS) has risen 32.74% since January 18, 2017 and is uptrending. It has outperformed by 16.04% the S&P500.

Virtus Investment Partners, Inc. is a publicly owned investment manager. The company has market cap of $933.05 million. The firm primarily provides its services to individual and institutional clients. It has a 24.36 P/E ratio. It launches separate client focused equity and fixed income portfolios.

Investors sentiment decreased to 1.36 in 2017 Q3. Its down 0.64, from 2 in 2017Q2. It dived, as 12 investors sold Virtus Investment Partners, Inc. shares while 32 reduced holdings. 16 funds opened positions while 44 raised stakes. 6.65 million shares or 1.17% less from 6.73 million shares in 2017Q2 were reported. Moreover, Great West Life Assurance Commerce Can has 0% invested in Virtus Investment Partners, Inc. (NASDAQ:VRTS) for 10,604 shares. The Ontario – Canada-based Savings Bank Of Montreal Can has invested 0% in Virtus Investment Partners, Inc. (NASDAQ:VRTS). Arrowstreet Cap Lp holds 4,400 shares. Pnc Fincl Svcs Group Inc Inc accumulated 0% or 158 shares. Quantitative Investment Llc holds 0% in Virtus Investment Partners, Inc. (NASDAQ:VRTS) or 3,300 shares. Arizona State Retirement invested 0.01% of its portfolio in Virtus Investment Partners, Inc. (NASDAQ:VRTS). Vanguard Group holds 674,882 shares. Barrow Hanley Mewhinney And Strauss Lc accumulated 33,724 shares. Marcato Capital L P reported 69,999 shares. Moreover, Citadel Advsr Ltd Liability Corporation has 0.01% invested in Virtus Investment Partners, Inc. (NASDAQ:VRTS) for 167,799 shares. Ny State Common Retirement Fund reported 7,200 shares. Bnp Paribas Arbitrage holds 0% in Virtus Investment Partners, Inc. (NASDAQ:VRTS) or 3,607 shares. Alliancebernstein L P owns 9,723 shares. Legal & General Group Public Ltd Co, United Kingdom-based fund reported 12,924 shares. Blackrock Incorporated reported 928,975 shares or 0.01% of all its holdings.

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company has market cap of $336.62 million. The firm operates in three divisions: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. It has a 52 P/E ratio. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations.

Since August 2, 2017, it had 0 buys, and 12 selling transactions for $551,995 activity. 2,000 Aceto Corporation (NASDAQ:ACET) shares with value of $20,690 were sold by Rogers Steven. $2,285 worth of stock was sold by GUCCIONE SALVATORE J SR on Tuesday, September 5. 3,016 Aceto Corporation (NASDAQ:ACET) shares with value of $31,591 were sold by DEBENEDITTIS FRANK. Shares for $99,744 were sold by EILENDER ALBERT L on Friday, September 1. Another trade for 6,500 shares valued at $68,049 was made by ROTH DOUGLAS A on Friday, September 1. Shares for $27,857 were sold by Kaczmarek Walter J III on Friday, September 1. Another trade for 309 shares valued at $3,225 was made by Scally Frances P on Friday, December 22.

Investors sentiment decreased to 1.28 in Q3 2017. Its down 0.17, from 1.45 in 2017Q2. It is negative, as 14 investors sold Aceto Corporation shares while 33 reduced holdings. 25 funds opened positions while 35 raised stakes. 23.93 million shares or 2.49% less from 24.54 million shares in 2017Q2 were reported. Renaissance Techs Ltd Liability Corp holds 268,200 shares or 0% of its portfolio. Millennium Ltd Llc holds 0.01% or 493,008 shares. Credit Suisse Ag holds 41,814 shares or 0% of its portfolio. Riverhead Limited Com owns 0% invested in Aceto Corporation (NASDAQ:ACET) for 2,754 shares. Metropolitan Life Ins New York owns 21,151 shares. Mason Street Advisors Limited Liability Company holds 7,626 shares. State Street invested in 805,790 shares or 0% of the stock. Champlain Invest Prns Ltd Liability has 1.00M shares. 14,282 were accumulated by Jpmorgan Chase Communications. Kbc Nv invested 0.01% in Aceto Corporation (NASDAQ:ACET). Northwestern Mutual Wealth Management holds 0% or 100 shares. 131,191 are owned by King Luther Cap Management. New York State Teachers Retirement Systems has 15,722 shares for 0% of their portfolio. Engineers Gate Manager L P invested 0.06% in Aceto Corporation (NASDAQ:ACET). Price T Rowe Assocs Md accumulated 36,480 shares or 0% of the stock.

Among 2 analysts covering Aceto (NASDAQ:ACET), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Aceto had 6 analyst reports since March 31, 2016 according to SRatingsIntel. First Analysis downgraded it to “Equal-Weight” rating and $21 target in Monday, November 14 report. The company was maintained on Monday, August 28 by Canaccord Genuity. On Monday, November 6 the stock rating was maintained by Canaccord Genuity with “Buy”. Canaccord Genuity maintained Aceto Corporation (NASDAQ:ACET) on Sunday, October 29 with “Buy” rating. The stock of Aceto Corporation (NASDAQ:ACET) has “Overweight” rating given on Thursday, March 31 by First Analysis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: